A gradual decrease over time occurred in the naïve CD8+ T cells of COVID-19 patients, with the 2 weeks, 6 weeks, and 6-7 month time points presenting significantly decreased fractions of these cells compared to healthy controls (Figure 3B). This evidence concerns the gene CD8A and COVID-19.